ARTICLES BY THIS AUTHOR
- 5/31/2021
NACDS, NCPA laud Texas law regulating PBMs
Texas House Bill 1763 ensures fair and adequate reimbursement for all pharmacies. - 5/31/2021
Alkermes receives FDA nod for Lybalvi
Alkermes' Lybalvi provides a treatment for adults with certain mental disorders, including schizophrenia and bipolar I. - 5/31/2021
Sandoz offers generic Remodulin for subcutaneous administration
The introduction of the RG 3-ml Medication Cartridge has enabled subcutaneous administration of Sandoz's treprostinil injection for the first time. - 5/31/2021
Glenmark intros generic Banzel
Banzel tablets had a market value of $285.3 million for the 12-month period ended April 2021, according to IQVIA. - 5/27/2021
FDA clears preventive indication for Nurtec ODT
This new approval makes Nurtec ODT the first oral CGRP antagonist approved for the preventive treatment of migraine, and the only migraine medication approved as a dual therapy for both the acute and preventive treatment. - 5/27/2021
Zydus Cadila launches biosimilar Ujvira
The launch marks the world’s first biosimilar antibody drug conjugate of trastuzumab emtansine. - 5/27/2021
Foresee Pharmaceuticals receives FDA nod for Camcevi
Camcevi 42 mg subcutaneous injection is a gonadotropin-releasing hormone agonist indicated for the treatment of adult patients with advanced prostate cancer. - 5/27/2021
Kroger launches $5M giveaway to encourage COVID-19 vaccinations
Kroger’s giveaway, starting next week, will give people who have received their vaccine from Kroger Health a shot at winning one of five $1 million payouts totaling $5 million in cash prizes and a chance to win free groceries for a year. - 5/26/2021
Upsher-Smith, Rafarm intro generic Vigamox
The moxifloxacin ophthalmic solution had a market value of approximately $34 million for the 12 months ended March 2021, according to IQVIA. - 5/26/2021
FDA grants emergency use authorization for GSK’s COVID-19 treatment
The authorization allows Sotrovimab to be distributed and administered as a 500 mg single dose intravenously by healthcare providers.